Drug Stock Poised to Lose Half its Value After Dismal Data

Conatus Pharmaceuticals' fatty liver disease drug did not meet its main goals

Managing Editor
Dec 6, 2018 at 9:14 AM
facebook X logo linkedin


The shares of Conatus Pharmaceuticals Inc (NASDAQ:CNAT) are down a whopping 50% in electronic trading, after the drug developer's mid-stage study of a treatment for fatty liver disease failed to meet its main goals. In response, Stifel downgraded the stock to "hold" from "buy," while slashing its price target to $4 from $10. In addition, three other brokerages chimed in with cuts of their own, including to $10 from $14 at Oppenheimer.

Should today's price action pan out, this would be CNAT's worst single-day loss ever, and the shares will hit a new annual low. Prior to today's drop, the stock had seemingly found support near the $4.20-$4.50 area, home to its post-bull gap level from early April. Conatus shares closed Tuesday at $4.50.

Prior to today, analysts were overwhelmingly bullish. All five of the brokerages in coverage rated CNAT a "strong buy." Furthermore, it's average 12-month price target sits all the way up at $12, territory the security has not traded near since early 2014.

Pessimism has been ramping up in the options pits, though, despite limited absolute volume. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), CNAT stock's 10-day put/call volume ratio of 0.33 ranks in the 95th annual percentile. While this shows that more calls than puts have been bought to open on an absolute basis, the rate of put buying relative to call buying has been quicker than usual.

 

*SPONSORED CONTENT*

How to collect 1 dividend check every day for LIFE

Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605! For me, I'm collecting 70 dividend checks every quarter…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week. Click here for all the details.

*SPONSORED CONTENT*